Solvonis Therapeutics plc (LON:SVNS)
0.2400
+0.0100 (4.35%)
At close: Mar 26, 2026
37.14% (1Y)
| Market Cap | 15.65M +313.2% |
| Revenue (ttm) | n/a |
| Net Income | -2.59M |
| EPS | -0.00 |
| Shares Out | 6.81B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 52,877,920 |
| Average Volume | 30,185,707 |
| Open | 0.2300 |
| Previous Close | 0.2300 |
| Day's Range | 0.2220 - 0.2500 |
| 52-Week Range | 0.1095 - 0.4000 |
| Beta | 1.38 |
| RSI | 46.90 |
| Earnings Date | Apr 16, 2026 |